Company Pharmacyclics, Inc.
Equities
US7169331060
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
2015 | Alexion Pharmaceuticals : to bolster rare disease offering with $8.4 billion deal | RE |
2015 | Mylan NV : Exclusive - Perrigo expected to reject Mylan's latest offer | RE |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 15-04-30 | |
Betty Chang
CTO | Chief Tech/Sci/R&D Officer | - | 13-07-08 |
Heow Tan
CTO | Chief Tech/Sci/R&D Officer | 65 | 12-04-30 |
Alvina Chu
PRN | Corporate Officer/Principal | - | - |
Danelle James
PRN | Corporate Officer/Principal | - | - |
Thorsten Graef
PRN | Corporate Officer/Principal | - | 13-07-08 |
Dana Lee
PRN | Corporate Officer/Principal | 60 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 77,079,177 | 62,948,561 ( 81.67 %) | 0 | 81.67 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- Stock
- Company Pharmacyclics, Inc.